Basel Medical Group Ltd (Nasdaq: BMGL) has entered exclusive negotiations for a $1 billion acquisition of Bitcoin (BTC), marking a major shift in its financial strategy. The move will reshape the company’s treasury reserves while continuing its focus on healthcare expansion across Asia.
BMGL stated that the deal is being structured through a share-swap arrangement involving institutional investors and high-net-worth individuals from the cryptocurrency sector. This initiative, once completed, is expected to position BMGL among the most financially flexible medical service providers in Asia-Pacific.
Advertisement
Advertisement
BMGL is aiming to build a stronger financial base to accelerate its expansion into emerging Asian healthcare markets. The proposed transaction would diversify the company’s balance sheet and improve its access to capital for future acquisitions.
Dr. Darren Chhoa, Chief Executive Officer of BMGL, said, “This $1 billion financial transformation will give us the capacity to execute our Asia growth strategy while maintaining conservative financial management.” He added that the move supports the firm’s mission to become a top-tier healthcare platform across the region.
The company is currently working with a group of crypto-focused investors to finalize terms. BMGL expects the deal to close within the current financial quarter, pending regulatory approvals and other standard conditions.
This Is A Developing Story, Please Check Back for More
Advertisement
✓ Share:
